Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,585 across all filing types
Latest filing 2019-03-25 Director's Dealing
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2019-03-25 English
4 Filing
Director's Dealing
2019-03-22 English
4/A Filing
Director's Dealing
2019-03-22 English
10-K Filing
Annual Report FY 2018
2019-03-15 English
S-8 Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans and employee stock purchase plans. It includes details about the securities to be registered, calculation of registration fees, indemnification of directors and officers, and incorporation by reference of other filings. It is not a financial report, earnings release, or management discussion, but rather a capital raising and securities registration filing related to employee stock plans. Therefore, it fits the category of Capital/Financing Update filings.
2019-03-15 English
4 Filing
Director's Dealing
2019-03-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.